GLUCOLEADER ENHANCE SELF-MONITORING OF BLOOD GLUCOSE SYSTEM— 510(k) K032985

Substantially Equivalent

Hmd Biomedical, Inc.

FDA 510(k) clearance K032985 for GLUCOLEADER ENHANCE SELF-MONITORING OF BLOOD GLUCOSE SYSTEM, Substantially Equivalent on 2003-10-21. Applicant: Hmd Biomedical, Inc.. Device class: 2.

Clearance details

Applicant
Hmd Biomedical, Inc.
Product code
Code NBW
Device class
Class 2
Regulation
21 CFR 862.1345
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Ocean, NJ, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code NBW

view all

More clearances from Hmd Biomedical, Inc.

view all

Adverse events under product code NBW

product code NBW
Death
18
Injury
4,740
Malfunction
42,679
Other
6
Total
47,443

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.